Search “nattokinase” and “varicose veins” together and you’ll find plenty of confident claims. What you won’t find as easily is a clear picture of what’s actually been studied.
Nattokinase has real research behind its effects on blood flow and clotting markers. Varicose veins specifically are a much thinner part of that picture.
This guide separates what’s been measured directly from what’s still more assumption than evidence.
Medical Overview
Varicose veins develop when the valves inside leg veins stop working efficiently, letting blood pool and flow sluggishly instead of moving back toward the heart. That slower flow, sometimes called blood stasis, is associated with localized oxidative stress and changes in blood and vessel wall properties in the affected veins.
Nattokinase’s research base connects to this picture indirectly, through its effects on blood viscosity and clotting-related markers, rather than through trials that treated varicose veins directly as the primary outcome.
Varicose veins with significant symptoms, pain, or skin changes should be evaluated by a doctor, since some cases need medical or procedural treatment beyond what any supplement addresses.
What’s Actually Been Studied: Blood Flow and Viscosity
The strongest circulation-related evidence for nattokinase isn’t about varicose veins specifically — it’s about blood viscosity and flow at a more general level.
An in vitro study from researchers at the University of Southern California incubated blood samples with nattokinase and measured red blood cell aggregation and whole blood viscosity. The results showed a significant, dose-dependent decrease in both red blood cell aggregation and low-shear blood viscosity — meaning the blood flowed more easily at the concentrations tested. This was a laboratory (in vitro) study, not a human trial, so it shows what nattokinase can do to blood outside the body rather than confirming the same effect at typical supplement doses inside a person.
Human evidence on peripheral blood flow comes from a randomized, placebo-controlled crossover trial, where healthy adult men took a single 2,000 FU dose of nattokinase and were then tested on how quickly their skin temperature recovered after cold water immersion — a recognized marker of peripheral blood flow. The nattokinase group showed measurably faster recovery than placebo, suggesting a short-term effect on peripheral circulation.
What’s Been Studied in Vascular Disease Patients
One study looked at nattokinase specifically in people already being treated for vascular conditions, including patients admitted for phlebitis and vein surgery. This observational safety study followed patients in vascular surgery settings, some of whom received nattokinase (100 mg/day) alongside their standard treatment, including patients who underwent surgery for varicose veins.
The primary focus of this study was safety, not effectiveness — it tracked adverse drug reactions and interactions over a 6-month follow-up period, not whether nattokinase measurably improved vein appearance or symptoms. It’s useful for understanding how nattokinase was tolerated in a real-world vascular disease population, but it isn’t a controlled trial that isolated nattokinase’s effect on varicose veins themselves.
Where the Evidence Gets Thin
This is the honest gap: there is no randomized, controlled clinical trial that set out specifically to test whether nattokinase improves the appearance, size, or symptoms of varicose veins in humans. What exists instead is a mix of related, indirect evidence: mechanistic research on fibrin breakdown, in vitro blood viscosity data, and clinical use in vascular disease patients that wasn’t designed to isolate a varicose-vein-specific outcome.
Some patent filings and practitioner writings describe varicose vein improvement anecdotally, based on nattokinase’s known effect on blood viscosity and clotting. That’s a reasonable mechanistic hypothesis, but it’s not the same as a clinical trial confirming the outcome, and it shouldn’t be presented as though it is.
What This Means Practically
If you’re considering nattokinase for general circulation support — sluggish-feeling blood flow, high blood viscosity markers — there’s more direct research to point to, including the viscosity and peripheral blood flow studies above.
If you’re specifically hoping nattokinase will visibly reduce or resolve varicose veins, the current evidence doesn’t support that as a confirmed outcome. Varicose veins that are painful, worsening, or causing skin changes are worth evaluating with a doctor, who can discuss options like compression therapy or procedural treatment that do have direct clinical evidence behind them.
Because nattokinase affects clotting, anyone on blood-thinning medication should also check with a doctor before using it for circulation purposes — covered in more detail in our guide to nattokinase and blood thinner interactions.
FAQs
There’s no clinical trial confirming this. The evidence connects nattokinase to blood viscosity and flow markers, not to a measured reduction in vein size or appearance.
There’s more direct evidence here than for varicose veins specifically — including a study showing improved peripheral blood flow recovery after a single dose, and lab research showing reduced blood viscosity.
Compression therapy has direct clinical evidence for reducing varicose vein symptoms and is generally considered first-line, non-invasive treatment. Nattokinase’s evidence is indirect and mechanistic by comparison.
This should be discussed with your doctor, especially since nattokinase affects clotting and some vascular treatments involve procedures where bleeding risk matters.
If your varicose veins are painful, rapidly worsening, or accompanied by skin discoloration or swelling, see a doctor rather than relying on a supplement. These can be signs that warrant direct evaluation.
Final Thoughts
Nattokinase has real, measured effects on blood viscosity and short-term peripheral blood flow. Its use specifically for varicose veins is much less established — supported by mechanism and anecdote more than by a dedicated clinical trial.
Nattokinase is not a treatment for varicose veins, and shouldn’t replace a medical evaluation for veins that are symptomatic or worsening.
If circulation support in general is your goal, see our full comparison of top-rated products: Best Nattokinase Supplements.